Advanced search
Publication Cover
Leukemia & Lymphoma Volume 52, 2011 - Issue 10
Submit an article Journal homepage
722
Views
25
CrossRef citations to date
0
Altmetric
Original Article: Clinical

A randomized trial with melphalan and prednisone versus melphalan and prednisone plus thalidomide in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplant

Stefano SacchiDepartment of Oncology and Hematology, University of Modena and Reggio Emilia, Modena, ItalyCorrespondence[email protected]
,
Raffaella MarcheselliDepartment of Oncology and Hematology, University of Modena and Reggio Emilia, Modena, Italy
,
Antonio LazzaroDivision of Medical Oncology and Hematology, Piacenza Hospital, Piacenza, Italy
,
Fortunato MorabitoHematology Unit, Department of Internal Medicine, Cosenza Hospital, Cosenza, Italy
,
Alberto FragassoHematology Unit, Matera Hospital, Matera, Italy
,
Nicola Di Renzo Hematology Unit, Vito Fazzi Hospital, Lecce, Italy
,
Enrico Balleari Department of Internal Medicine, University of Genoa, Genoa, Italy
,
Santo Neri Division of Hematology, Papardo Hospital, Messina, Italy
,
Giovanni Quarta Division of Hematology, Perrino Hospital, Brindisi, Italy
,
Raimondo FerraraOncology Unit, Barletta Hospital, Barletta, Italy
,
Maria Luigia VigliottiOnco-Hematology Unit, Caserta Hospital, Caserta, Italy
,
Giuseppe PolimenoDivision of Medicine, Miulli Hospital, Acquaviva delle Fonti, Barletta, Italy
,
Pellegrino MustoUnit of Hematology and Stem Cell Transplantation, IRCCS-CROB, Oncology Referral Center of Basilicata, Rionero in Vulture, Potenza, Italy
,
Ugo ConsoliOnco-Hematology Unit, Garibaldi-Nesina Hospital, Catania, Italy
,
Alessandra ZoboliDivision of Medicine, Correggio Hospital, Correggio, Reggio Emilia, Italy
,
Gabriele BudaDepartment of Oncology, Division of Hematology, University of Pisa, Pisa, Italy
,
Alessandro PastoriniHematology Unit, Sondalo Hospital, Sondalo, Sondrio, Italy
&
Luciano MasiniDepartment of Hematology, Santa Maria Nuova Hospital, Reggio Emilia, Italy
 show all
Pages 1942-1948 | Received 21 Feb 2011, Accepted 19 Apr 2011, Published online: 12 Jun 2011

References

  • International Agency for Research on Cancer (IARC). Globocan 2008. Cancer incidence and mortality worldwide in 2008. Available from: http://globocan.iarc.fr/.
  • Singhal S, Mehta J, Desikan R, et al. Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med 1999;34:1565–1571.
  • Palumbo A, Bringhen S, Caravita T, et al. Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial. Lancet 2006;367:825–831.
  • Facon T, Mary JY, Hulin C, et al. Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial. Lancet 2007;370:1209–1218.
  • Palumbo A, Bringhen S, Liberati AM, et al. Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial. Blood 2008;112:3107–3114.
  • Hulin C, Facon T, Rodon P, et al. Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01/01 trial. JClin Oncol 2009;27:3664–3670.
  • Wijermans P, Schafsma M, Termorschuizen F, et al. Phase III study of the value of thalidomide added to melphalan plus prednisone to elderly patients with newly diagnosed multiple myeloma: the HOVON 49 study. J Clin Oncol 2010;28:3160–3166.
  • Waage A, Gimsing P, Fayers P, et al. Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma. Blood 2010;116:1405–1412.
  • Beksac M, Haznedar R, Firatli-Tuglular T, et al. Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group. Eur J Haematol 2011;86:16–22.
  • Bladé J, Samson D, Reece D, et al. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation.Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant. Br J Haematol 1998;102:1115–1123.
  • Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457–481.
  • Cox D. Regression models and life tables. J R Stat Soc B 1972;34:187–202.
  • Shoenfeld D. Partial residuals for the proportional hazard regression model. Biometrika 1982;69:239–241.
  • Stata 10.1. College Station, TX: StataCorp.
  • Palumbo A, Rajkumar SV, Dimopoulos MA, Richardson PG, San Miguel J, Barlogie B. Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma. Leukemia 2008;22:414–423.
  • Kapoor P, Rajkumar SV, Dispenzieri A, et al. Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant ineligible patients with multiple myeloma: a meta-analysis. Leukemia. 2011;25:689–696.
  • Waage APP, Fayers P, Beksac M, et al. MP versus MPT for previously untreated elderly patients with multiple myeloma: a meta-analysis of 1,682 individual patient data from six randomized clinical trials. J Clin Oncol 2010; 28(15 suppl.): Abstract 8130.
  • National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: multiple myeloma, v.2. 2009. Available from: http://www.nccn.org/professionals/physician_ gls/PDF/myeloma.pdf

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.